LifeStance Health Group, Inc. (NASDAQ:LFST) Receives $8.63 Average PT from Brokerages

Shares of LifeStance Health Group, Inc. (NASDAQ:LFST) have been assigned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, one has given a hold rating, four have issued a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among analysts that have covered the stock in the last year is $8.58.

LFST has been the subject of a number of analyst reports. The Goldman Sachs Group raised shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 target price for the company in a research note on Monday, December 16th. Canaccord Genuity Group assumed coverage on shares of LifeStance Health Group in a research note on Thursday, April 3rd. They issued a “buy” rating and a $8.00 price target for the company. William Blair reiterated an “outperform” rating on shares of LifeStance Health Group in a report on Friday, February 28th. Finally, KeyCorp began coverage on shares of LifeStance Health Group in a report on Tuesday. They set an “overweight” rating and a $9.00 price target on the stock.

Insider Buying and Selling

In related news, insider Lisa K. Miller sold 18,845 shares of the company’s stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $6.90, for a total transaction of $130,030.50. Following the sale, the insider now owns 339,810 shares of the company’s stock, valued at approximately $2,344,689. This represents a 5.25 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 6.60% of the stock is currently owned by insiders.

Hedge Funds Weigh In On LifeStance Health Group

Institutional investors have recently made changes to their positions in the stock. Blue Trust Inc. increased its holdings in shares of LifeStance Health Group by 124.4% in the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock worth $27,000 after buying an additional 2,122 shares during the last quarter. Townsquare Capital LLC purchased a new stake in shares of LifeStance Health Group in the 3rd quarter valued at $73,000. R Squared Ltd purchased a new stake in shares of LifeStance Health Group in the 4th quarter valued at $80,000. Ameriprise Financial Inc. purchased a new stake in shares of LifeStance Health Group in the 4th quarter valued at $87,000. Finally, Cibc World Markets Corp purchased a new stake in shares of LifeStance Health Group in the 4th quarter valued at $96,000. Institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Stock Up 5.8 %

LifeStance Health Group stock opened at $6.91 on Thursday. The company’s 50-day moving average price is $7.33 and its two-hundred day moving average price is $7.33. The stock has a market cap of $2.66 billion, a P/E ratio of -26.58 and a beta of 1.30. LifeStance Health Group has a twelve month low of $4.64 and a twelve month high of $8.61. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.